Natalizumab for relapsing-remitting multiple sclerosis by A. Horga, M. Tintoré

“…Development: Several randomized clinical trials in patients with relapsing forms of multiple sclerosis have demonstrated that natalizumab substantially reduces clinical and radiological disease activity. …”
Get full text

The State of the Art of Pediatric Multiple Sclerosis by Raluca Ioana Teleanu, Adelina-Gabriela Niculescu, Oana Aurelia Vladacenco, Eugenia Roza, Radu-Stefan Perjoc, Daniel Mihai Teleanu

Subjects: “…pediatric multiple sclerosis…”
Get full text

Seizure characteristics in multiple sclerosis patients by Vahid Shaygannejad, Fereshteh Ashtari, Mohammad Zare, Majid Ghasemi, Rasul Norouzi, Helia Maghzi

Subjects: Get full text

Update on immunopathogenesis and immunotherapy in multiple sclerosis by Selter RC, Hemmer B

Subjects: “…Multiple sclerosis…”
Get full text

Navigating choice in multiple sclerosis management by Ralf A. Linker, Andrew Chan

“…Abstract Background With the advent of modern immunotherapies for relapsing-remitting multiple sclerosis (RRMS) and the increasing amount of treatment options on the market, MS has evolved as a treatable disease. …”
Get full text

Effect of pregnancy on the course of multiple sclerosis by A. I. Мuravin, А. N. Boyko, E. V. Popova, A. V. Murashkо

Subjects: Get full text

How Early Is Early Multiple Sclerosis? by Sotiria Stavropoulou De Lorenzo, Christos Bakirtzis, Natalia Konstantinidou, Evangelia Kesidou, Dimitrios Parissis, Maria Eleptheria Evangelopoulos, Dina Elsayed, Eman Hamdy, Sameh Said, Nikolaos Grigoriadis

Subjects: “…multiple sclerosis…”
Get full text

Multiple Sclerosis and the Endogenous Opioid System by Zoë Dworsky-Fried, Caylin I. Chadwick, Bradley J. Kerr, Bradley J. Kerr, Bradley J. Kerr, Anna M. W. Taylor, Anna M. W. Taylor, Anna M. W. Taylor

Subjects: “…multiple sclerosis…”
Get full text

Bacteria–Host Interactions in Multiple Sclerosis by Davide Cossu, Davide Cossu, Kazumasa Yokoyama, Kazumasa Yokoyama, Nobutaka Hattori, Nobutaka Hattori

Subjects: Get full text

MONOCLONAL ANTIBODY FOR MULTIPLE SCLEROSIS TREATMENT by E. V. Popova

“…Since beginning of this century monoclonal antibodies began to be explored for the treatment of multiple sclerosis (MS). From this period monoclonal antibody also actively introduced in pathogenetic therapy of MS. …”
Get full text

Total knee arthroplasty in multiple sclerosis by Kaitlyn E. Hughes, Darren Nickel, Tanner Gurney-Dunlop, Katherine B. Knox

Subjects: “…Multiple sclerosis…”
Get full text

Association of celiac disease with multiple sclerosis by Abolfazli.R, Mirbagheri.A, Rabbani Anari M

“…  Background: Multiple sclerosis (MS) and the gluten intolerance disease, celiac disease, (CD) are immune-mediated diseases. …”
Get full text

Microglia Diversity in Health and Multiple Sclerosis by Sameera Zia, Khalil S. Rawji, Nathan J. Michaels, Mena Burr, Bradley J. Kerr, Bradley J. Kerr, Luke M. Healy, Jason R. Plemel, Jason R. Plemel

Subjects: Get full text

Multiple sclerosis: New insights and trends by Khaled Mohamed Mohamed Koriem

Subjects: “…Multiple sclerosis…”
Get full text

Clinical trials in multiple sclerosis: milestones by Yinan Zhang, Amber Salter, Gary Cutter, Olaf Stüve

“…The achievements in multiple sclerosis (MS) therapeutics are founded on the outcomes of clinical trials that demonstrate quantifiable results in treating a disease with an unpredictable course. …”
Get full text

Schistosomiasis protects against multiple sclerosis by Anne Camille La Flamme, Kanishka Canagasabey, Marina Harvie, B Thomas Bäckström

Subjects: Get full text

Concurrent gliomas in patients with multiple sclerosis by Katharina Sahm, Tobias Kessler, Philipp Eisele, Miriam Ratliff, Elena Sperk, Laila König, Michael O. Breckwoldt, Corinna Seliger, Iris Mildenberger, Daniel Schrimpf, Christel Herold-Mende, Pia S. Zeiner, Ghazaleh Tabatabai, Sven G. Meuth, David Capper, Martin Bendszus, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten

“…In line, inflammatory disease activity increases in 42% of multiple sclerosis patients after brain tumor radiotherapy suggesting a susceptibility of multiple sclerosis brain tissue to pro-inflammatory stimuli such as ionizing radiation. …”
Get full text

Siponimod in secondary progressive multiple sclerosis by Jamir Pitton Rissardo, Ana Leticia Fornari Caprara

Get full text

Neuroplasticity and motor rehabilitation in Multiple Sclerosis by Ilona eLipp, Ilona eLipp, Valentina eTomassini, Valentina eTomassini, Valentina eTomassini

Subjects: “…Multiple Sclerosis…”
Get full text

Hearing loss in multiple sclerosis patients by Saberi A (MD), Naghavi SE (MD), Hatamian HR (MD), Banan R (MD), Nemati Sh (MD), Kazemnejad E (PhD), Pouryazdanpanah D (MD)

Subjects: “…Multiple sclerosis…”
Get full text